Cognitive Research Funding: How Much Did They Raise & Key Investors

How Much Did Cognitive Research Raise?
Funding & Key Investors

Cognitive Research Corporation has solidified its market position through a series of strategic capital injections, culminating in a recent financing event of $0. This latest infusion of capital brings the firm's cumulative backing to $350K, underscoring investor confidence in the company's specialized approach to Central Nervous System (CNS) product development. As a late-stage entity, the organization continues to leverage its unique dual-model of clinical research services and proprietary assessment technology to maintain a competitive edge in the global pharmaceutical and biotechnology landscape.

The trajectory of this growth reflects a sustained commitment to high-precision clinical study management, spanning Phase I through Phase IV trials. By securing this latest round of investment, the company is well-positioned to scale its operational capacity and further integrate its advanced psychometric tools into broader international research frameworks.

What is Cognitive Research?

Cognitive Research

Business Services

Research & Development

Cognitive Research Corporation (CRC) operates as a specialized contract research organization (CRO) with a distinct focus on the complex requirements of Central Nervous System (CNS) product development. The firm serves a diverse clientele, including pharmaceutical, nutraceutical, biotechnology, and medical device companies, providing comprehensive, quality-driven clinical study support. Beyond its core CRO services, CRC distinguishes itself through the development of CogScreen, a world-leading computerized psychometric battery. This technology provides highly sensitive measurements of cognitive domains such as attention, memory, information processing, and executive function, positioning the company as a critical partner in the assessment of neurological and psychiatric interventions.

How much funding has Cognitive Research raised?

Cognitive Research has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in Cognitive Research

PPP

Public-Private Partnership

What's next for Cognitive Research?

With the recent influx of capital, Cognitive Research Corporation is expected to prioritize the expansion of its clinical trial infrastructure and the continued refinement of its proprietary assessment technologies. The strategic focus will likely shift toward enhancing the scalability of its CNS-focused research services to meet the increasing demand for specialized data in drug development. Furthermore, the company is poised to leverage its established reputation to capture a larger share of the medical device and biotechnology testing market, ensuring that its psychometric batteries remain the industry standard for cognitive assessment. By maintaining a focus on efficiency and high-quality data, CRC is set to navigate the complexities of late-stage clinical development while driving innovation in neurological research.

See full Cognitive Research company page

See More Financial Insights